SCHEMBL5045481

SCHEMBL5045481

Cc1cc(-c2ccc(Cl)cc2)nc2c(C(=O)Nc3cccc(S(C)(=O)=O)c3)cnn12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
POLB P06746 3/20 0.51
MAPT P10636 2/20 0.51
GBA1 P04062 2/20 0.51
MAPK1 P28482 1/20 0.51
KDM4E B2RXH2 5/20 0.50
KMT2A Q03164 3/20 0.50
HTT P42858 1/20 0.50
TP53 P04637 3/20 0.49
CA2 P00918 3/20 0.49
CA9 Q16790 3/20 0.49
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
SCN2A Q99250 1/20 0.47
SCN10A Q9Y5Y9 1/20 0.47
THRB P10828 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5045912 0.93 MAPK1 (0.52) ALDH1A1POLBMAPTGBA1MAPK1
SCHEMBL5041944 0.92 CA2 (0.59) ALDH1A1POLBMAPTGBA1MAPK1
SCHEMBL5042025 0.89 MAPK1 (0.51) ALDH1A1POLBMAPTGBA1MAPK1
SCHEMBL5044930 0.89 KDM4E (0.54) ALDH1A1POLBMAPTMAPK1KDM4E
SCHEMBL5049518 0.89 MAPK1 (0.49) ALDH1A1POLBMAPTMAPK1KDM4E
SCHEMBL5046768 0.88 HSD17B10 (0.56) ALDH1A1POLBMAPTMAPK1KDM4E
SCHEMBL5048443 0.88 MAPK1 (0.50) ALDH1A1POLBMAPK1KDM4EKMT2A
SCHEMBL5044950 0.87 MAPK1 (0.48) ALDH1A1POLBMAPTMAPK1KDM4E
SCHEMBL5044931 0.86 KIF18A (0.52) ALDH1A1POLBMAPTGBA1MAPK1
SCHEMBL5039369 0.85 CA2 (0.43) ALDH1A1MAPTMAPK1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378417-B2 Pyrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US claimed
US-20050282827-A1 Pyrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 US claimed
US-7378417-B2 Pyrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US disclosed
US-20050282827-A1 Pyrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282827-A1 Pyrazolo-pyrimidine derivatives P2RX3, P2RX1, P2RX5 ALDH1A1 1028/4885POLB 2158/4885MAPT 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.